Humanistic Burden of (FSGS) Focal Segmental Glomerulosclerosis and IgAN (Immunoglobulin A Nephropathy)
Clinical trial NCT05200871 · COMPLETED
Trial details
- NCT number
- NCT05200871
- Sponsor
- Travere Therapeutics, Inc.
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-02-05
- Primary completion
- 2023-10-31
- Enrollment
- 487
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.